Table 2.
Baseline characteristics of the IRT vs. NO-IRT cohorts.
| IRT | NO-IRT | p-value | |
|---|---|---|---|
| n = 45 | n = 17 | ||
| Age | 56.4 ± 9.1 | 60.6 ± 10.8 | 0.13 |
| Sex, males | 82.2 (37) | 82.4 (14) | 0.72 |
| Risk factors and comorbidities | |||
| Alcohol | 28.9 (13) | 23.5 (4) | 0.72 |
| Tobacco | 40.0 (18) | 29.5 (5) | 0.53 |
| Atrial fibrilation | 8.9 (4) | 11.8 (2) | 0.64 |
| Hypertension | 66.7(30) | 47.1 (8) | 0.23 |
| Dyslipidemia | 46.7 (21) | 23.5 (4) | 0.09 |
| Diabetes mellitus | 25.0 (11) | 5.9 (1) | 0.15 |
| Obesity | 29.5 (13) | 29.4 (5) | 1 |
| Previous exercise | 38.1 (16) | 41.2 (7) | 0.8 |
| Cardiopathy | 11.8 (2) | 4.4 (2) | 0.3 |
| Osteoarticular | 8.9 (4) | 23.5 (4) | 0.18 |
| Psychiatric | 20 (9) | 5.9 (1) | 0.26 |
| Previous medication | |||
| Anti-platelets | 22.2 (10) | 17.6 (3) | 1 |
| Anticoagulants | 4.4 (2) | 5.9 (1) | 1 |
| Statins | 46.7 (21) | 17.6 (3) | 0.03 |
| Anti- hypertensives | 55.6 (25) | 47.1 (8) | 0.58 |
| Anti-diabetic | 22.2(10) | 5.9 (1) | 0.26 |
Variables are expressed as a percentage (number of cases) or mean ± SD. Differences were assessed with a t-test, chi-square test, or Fisher exact test.
Statistically significant differences are highlighted in bold.